Radiation Therapy

Treatment for Brain And Central Nervous System Cancer

Typical Dosage: 60 Gy in 30 fractions

Effectiveness
60%
Safety Score
25%
Clinical Trials
658
Participants
50K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
25
DangerousModerateSafe
Treatment Details
Dosage Range
60 Gy in 30 fractions
Time to Effect
3-6 months
Treatment Duration
6 weeks
Evidence Quality
HIGH
Number Needed to Harm (NNH)
15(Treat 15 patients to see 1 additional serious adverse event)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$10,000
Side Effect Mgmt:$3,000
Total Annual:$48,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOOD
QALYs Gained
0.1
Outcome-Based Costs
Cost per Responder
$106,667
Cost per Remission
$960,000
Radiation Therapy Outcomes

for Brain And Central Nervous System Cancer

Efficacy Outcomes
Overall Effectiveness
+60%
Response Rate
+45%
Remission Rate
+5%
Common Side Effects
Fatigue
+70%
Hair loss
+90%
Skin irritation
+60%
Nausea/Vomiting
+30%
Cognitive impairment (long-term)
+40%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov

Completed Clinical Trials
16 completed trials for Radiation Therapy in Brain And Central Nervous System Cancer

A Study for Image-Guided Radiation Therapy in Pediatric Brain Tumors and Side Effects

NCT00187226COMPLETEDPHASE2
View Study
361 participants
INTERVENTIONAL
Memphis, United States
Started: Jun 1, 1997

Study of GDC-0084 in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline Gliomas

NCT03696355COMPLETEDPHASE1
View Study
27 participants
INTERVENTIONAL
Memphis, United States
Started: Nov 19, 2018

Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma

NCT00895622COMPLETEDPHASE2
View Study
244 participants
INTERVENTIONAL
Phoenix, United States +77 more
Started: Jun 1, 2009

Radiation Therapy in Treating Young Patients With Gliomas

NCT00238264COMPLETEDPHASE2
View Study
92 participants
INTERVENTIONAL
Birmingham, United States +144 more
Started: Nov 1, 2006

Standard Radiation Therapy, Higher-Dose Radiation Therapy, or Chemotherapy in Treating Older Patients With Glioblastoma Multiforme

NCT00820963COMPLETEDPHASE3
View Study
70 participants
INTERVENTIONAL
Lyon, France
Started: Jul 1, 2006

Boron Neutron Capture Therapy, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

NCT00974987COMPLETEDPHASE2
View Study
32 participants
INTERVENTIONAL
Takatsuki, Japan
Started: Sep 1, 2009

Capecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade Glioma

NCT00357253COMPLETEDPHASE1
View Study
24 participants
INTERVENTIONAL
San Francisco, United States +11 more
Started: Jan 1, 2006

Temozolomide and Radiation Therapy in Treating Patients With Gliomas

NCT00114140COMPLETEDPHASE2
View Study
136 participants
INTERVENTIONAL
Phoenix, United States +46 more
Started: Jan 1, 2005

Radiation Therapy or Temozolomide in Treating Patients With Gliomas

NCT00182819COMPLETEDPHASE3
View Study
709 participants
INTERVENTIONAL
Randwick, Australia +88 more
Started: Jul 1, 2005

Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme

NCT00003417COMPLETEDPHASE1, PHASE2
View Study
40 participants
INTERVENTIONAL
Birmingham, United States +236 more
Started: Sep 1, 1998

Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

NCT00004073COMPLETEDPHASE2
View Study
54 participants
INTERVENTIONAL
Birmingham, United States +8 more
Started: Dec 1, 1999

Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

NCT00028678COMPLETEDPHASE2
View Study
45 participants
INTERVENTIONAL
Tampa, United States +11 more
Started: Jul 11, 2002

Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas

NCT00033280COMPLETEDPHASE2
View Study
42 participants
INTERVENTIONAL
Mobile, United States +38 more
Started: Jul 1, 2002

Cytochlor, Tetrahydrouridine, and External-Beam Radiation Therapy in Treating Patients With Cancer That Has Spread to the Brain

NCT00521183COMPLETEDPHASE1
View Study
2 participants
INTERVENTIONAL
Miami, United States
Started: Jun 1, 2007

Radiation Therapy Plus Carboplatin and Lobradimil in Treating Children With Newly Diagnosed Brain Stem Gliomas

NCT00005602COMPLETEDPHASE1
View Study
13 participants
INTERVENTIONAL
Los Angeles, United States +18 more
Started: Feb 1, 2001

Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

NCT00006353COMPLETEDPHASE3
View Study
575 participants
INTERVENTIONAL
Calgary, Canada +15 more
Started: Jul 1, 2000
Showing 20 of 662 total trials